Key players in Celiac Disease Treatment
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 |  Takeda Pharmaceutical Company Ltd |
takeda.com (opens in a new tab) | 660 reports |
| 2 | Anokion | — | 33 reports |
| 3 |  Teva Pharmaceutical |
tevapharm.com (opens in a new tab) | 462 reports |
| 4 | ImmunogenX | — | 33 reports |
| 5 | Dr. Schar | — | 33 reports |
Also active in Celiac Disease Treatment
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
| Company | Where public records show them |
|---|---|
 Amneal Pharmaceuticals, Inc |
|
 Dr Reddy’s Laboratories |
|
| Hospira Inc | |
| Cipla Inc. | |
| Zydus Lifesciences | |
| Sciegen Pharmaceuticals | |
| Alembic Therapeutics | |
| Gland | |
| International Medication | |
| Orbicular | |
| Caplin | |
| TP Anda Holdings |
Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.
Celiac Disease Treatment reports by place
Australia
Brazil
Canada
China
Ecuador
Egypt
France
Germany
Hong Kong
India
Italy
Japan
Kenya
Malaysia
Mexico
New Zealand
PhilippinesGet the full Celiac Disease Treatment report
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.